Basic Information
IMAGEENS' artificial intelligence platform enables doctors to deliver precise and personalized medication in cardiovascular disease (CVD). We apply artificial intelligence and biomechanical models to cardiovascular magnetic resonance data, providing valuable medical insights for treatment decisions in cardiovascular diseases. Our award-winning platform has been tested on more than 4,000 patients, published over 80 articles, and is used in more than 22 leading clinical centers worldwide.
IMAGEENS
Paris,Ile-de-France,France
less than 15 people
March 01, 2017
--

